Sopharma Trading AD

SFT

BG1100086070

Pharmaceuticals

End-of-day quote Bulgaria S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
5.75 ^BGN	-0.86%		0.00%	-4.17%

Mar. 15	Sopharma Trading AD(BUL:SFT) dropped from SOFIX Index	CI
Feb. 29	Sopharma Trading AD Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Sopharma Trading : Блокиране и изтегляне на ПРОКСИД ЗА ЖЕНИ саше x 30 с партида 213340

January 05, 2023 at 09:58 am EST

Във връзка с уведомително писмо от Производителя, Констативен протокол 0042410/21.12.2022 и предписание 5423/21.12.2022 от БАБХ - гр. София, относно хранителни добавки, които съдържат в състава си N ацетил цистеин, се предприема блокиране и изтегляне на ПРОКСИД ЗА ЖЕНИ саше x 30 с партида 213340 - срок на годност 17.09.2023 и партида 210913 - срок на годност 03.2023.

Attachments

Original Link
Original Document
Permalink

Disclaimer

Sopharma Trading AD published this content on 05 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 January 2023 14:57:01 UTC.

Latest news about Sopharma Trading AD

Sopharma Trading AD(BUL:SFT) dropped from SOFIX Index	Mar. 14	CI
Sopharma Trading AD Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Sopharma Trading AD Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 29	CI
Sopharma Trading AD Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Sopharma Trading AD agreed to acquire 9 Outlets of Royal Pharmacy in Pernik, Dupnitsa and Radomir from Royal Pharmacy.	23-08-13	CI
Sopharma to Study Possible Acquisitions in Serbia	23-06-01	CI
Sopharma Trading AD Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Sopharma Trading AD(BUL:SFT) added to SOFIX Index	23-03-19	CI
Sopharma Trading AD Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
Sopharma Trading AD Reports Earnings Results for the Nine Months Ended September 30, 2022	22-11-28	CI
Sopharma Trading AD(BUL:SFT) dropped from SOFIX Index	22-09-16	CI
Sopharma Trading AD Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Sopharma Trading AD Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Sopharma Trading AD Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-28	CI
Sopharma Trading AD Reports Earnings Results for the Nine Months Ended September 30, 2021	21-11-29	CI
Sopharma Trading AD Announces Chief Executive Officer Changes	21-11-28	CI
Sopharma Trading AD Announces Board Changes	21-11-26	CI
Sopharma Trading Ad Announces Earnings Results for the Month and Year to Date Ended August 2021	21-09-29	CI
Sopharma Trading Appoints Ognyan Donev as New Chief Executive Officer Replacing Dimitar Dimitrov	21-09-23	CI
Sopharma Trading AD(BUL:SFT) added to SOFIX Index	21-09-20	CI
Sopharma Trading AD Reports Financial Results for the Month and Year to Date July 2020	21-08-20	CI
Sopharma Trading AD Reports Earnings Results for the Month and Year-To-Date Ended May 2021	21-06-23	CI
Sopharma Trading Ad Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-27	CI
Sopharma Trading AD Announces Revenue Results for the Month and Year to Date Ended April 2021	21-05-26	CI
Sopharma Trading Jsc. Announces Earnings Results for the Month of February 2021	21-03-29	CI

Chart Sopharma Trading AD

Duration

Period

More charts

Company Profile

Sopharma Trading AD (Sofarma Trading AD) is a Bulgaria-based company that is principally engaged in the distribution and wholesale of pharmaceuticals, drugs, medical supplies and facilities, food additives, vitamins and disinfectants. Its product portfolio includes more than 7,000 items. The Company operates warehouses and regional distributive centers in five cities in Bulgaria, the Company supplies its products to pharmacies, hospitals, clinics and other health care facilities. Sopharma Trading AD Sofia is a part of the Sopharma Group. As of December 31, 2011, the Companyâs major shareholder was Sopharma AD with a stake of 81.33%.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SOPHARMA TRADING AD	-4.17%	109M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+19.22%	15.14B
CIPLA LIMITED	+12.87%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.67%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B

Generic Pharmaceuticals

Sopharma Trading AD

Equities

SFT

BG1100086070

Pharmaceuticals

Sopharma Trading : Блокиране и изтегляне на ПРОКСИД ЗА ЖЕНИ саше x 30 с партида 213340

Latest news about Sopharma Trading AD

Chart Sopharma Trading AD

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Generic Pharmaceuticals